Hemoalgae Overview

Founded 2016
Status Private
Latest Deal Type Early Stage VC (Cancelled)
Investors 1

Hemoalgae General Information


Provider of a microalgae bio-based technological platform intended to develop high valuable compounds with added value through genetic engineering tools. The company's platform uses microalgae for the production of proteins and other compounds such as their first product, hirudin, enabling companies to produce complete hirudin in a more efficient, sustainable and cost-effective way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Other Healthcare Services
Primary Office
  • Cartago
  • Costa Rica
+506 8433 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hemoalgae Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 04-Dec-2018 Cancelled Generating Revenue
1. Accelerator/Incubator 01-Oct-2016 00000 00000 00.000 Completed Startup

Hemoalgae Executive Team (3)

Name Title Board Seat Contact Info
Myrka Zeledon Co-Founder & Chief Executive Officer
Diana Mendoza Solano Co-Founder & Chief Operating Officer
Luis Alfredo Barboza Fallas Co-Founder & CSO

Hemoalgae Investors (1)

To view Hemoalgae‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
RebelBio Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial